Keyphrases
Natural Killer Cells
100%
Cancer Cell Therapy
100%
K562
50%
Interleukin-2
37%
Interleukin-15 (IL-15)
25%
Peripheral Blood
25%
Expanded Natural Killer Cells
25%
Immunodeficient Mice
12%
Stimulation Method
12%
Clinical Grade
12%
Gene Expression Profile
12%
Interleukin-12 (IL-12)
12%
Murine Model
12%
CD56+
12%
Interleukin-21 (IL-21)
12%
Cancer Immunotherapy
12%
Acute Myeloid Leukemia
12%
Acute Myeloid Leukemia Cells
12%
Cell Therapy
12%
4-1BB
12%
Leukemia
12%
Membrane-bound Form
12%
Leukemia Cell Lines
12%
Enhanced Cytotoxicity
12%
Clinical Testing
12%
Emerging Tools
12%
CD3+ Lymphocytes
12%
Acute Leukemia
12%
Practical Platform
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Interleukin 2
100%
Leukemia
66%
Acute Myeloid Leukemia
66%
Interleukin 15
66%
CD3 Antigen
66%
Immunotherapy
33%
Interleukin 12
33%
Interleukin 21
33%
Acute Leukemia
33%
Cytotoxicity
33%
Medicine and Dentistry
Cancer Cell
100%
Natural Killer Cell
100%
Cell Therapy
100%
Interleukin 2
30%
Acute Myeloid Leukemia
20%
Interleukin 15
20%
CD3 Antigen
20%
In Vitro
10%
Infusion
10%
Gene Expression
10%
Malignant Neoplasm
10%
Cytotoxicity
10%
Leukemia Cell
10%
Cancer Immunotherapy
10%
Leukemia
10%
Interleukin 12
10%
K562 Cells
10%
Leukemia Cell Line
10%
Interleukin 21
10%
Acute Leukemia
10%
Lymphocyte
10%
Immunology and Microbiology
Cancer Cell
100%
Natural Killer Cell
100%
Interleukin 2
30%
Myeloid
20%
Interleukin 15
20%
CD3 Antigen
20%
Leukemia Cell Line
10%
Gene Expression
10%
Cytotoxicity
10%
Coculture
10%
Cancer Immunotherapy
10%
Interleukin 21
10%
Leukemia Cell
10%
Lymphocyte
10%
Interleukin 12
10%